Home > News > Altair Nanotechnologies to Present at the Wall Street Analyst Forum
February 25th, 2004
Altair Nanotechnologies to Present at the Wall Street Analyst Forum
Altair Nanotechnologies Inc. announced today that its President, Dr. Rudi Moerck, will be presenting to members of the financial community at the Wall Street Analyst Forum's Pharmaceutical Conference in New York City on March 1, 2004. Dr. Moerck will provide an overview of Altair Nanotechnologies' technology platform along with an in depth discussion and update of the company's patent-pending pharmaceutical, RenaZorb™. Additionally, Dr. Moerck will discuss the company's new nano-based drug delivery system that may possess properties that reduce the potential for the abuse of narcotics.
Haydale Secures Exclusive Development and Supply Agreement with Tantec A/S: New reactors to be built and commissioned by Tantec A/S represent another step forward towards the commercialisation of graphene October 24th, 2014
QuantumWise guides the semiconductor industry towards the atomic scale October 24th, 2014
Advancing thin film research with nanostructured AZO: Innovnano’s unique and cost-effective AZO sputtering targets for the production of transparent conducting oxides October 23rd, 2014
Strengthening thin-film bonds with ultrafast data collection October 23rd, 2014